Single-capsule bismuth quadruple therapy: preferable at the moment, but what should be next?

United European Gastroenterol J. 2021 Feb;9(1):7-8. doi: 10.1177/2050640620975357. Epub 2021 Feb 12.

Authors

Hidekazu Suzuki¹, Hideki Mori²

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
² Translational Research Center for Gastrointestinal Diseases (TARGID), University of Leuven, Leuven, Belgium.

No abstract available

Publication types

Editorial

MeSH terms

Antacids / administration & dosage
Antacids / therapeutic use*
Anti-Bacterial Agents / administration & dosage
Anti-Bacterial Agents / therapeutic use*
Bismuth / administration & dosage
Bismuth / therapeutic use*
Capsules
Drug Combinations
Drug Therapy, Combination
Helicobacter Infections / drug therapy*
Helicobacter pylori
Humans
Medication Adherence
Proton Pump Inhibitors / administration & dosage
Proton Pump Inhibitors / therapeutic use*

Substances

Antacids
Anti-Bacterial Agents
Capsules
Drug Combinations
Proton Pump Inhibitors
Bismuth